Multisystem Toxicity in Cancer: Lessons from NASA's Countermeasures Program.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31730844.
- Also identified by DOI 10.1016/j.cell.2019.10.024 and PMC identifier 7380275.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Astronauts and cancer patients are subject to similar multisystem physiological toxicities. Over the past sixty years, NASA developed a state-of-the-art countermeasures program (CMP) to characterize and mitigate the physiological consequences of spaceflight. Here, we propose a NASA-modeled CMP to elucidate and abrogate physiological toxicities in patients with cancer.
Medical subject headings
- Neoplasms
- United States National Aeronautics and Space Administration